|
STXBP3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.8124999945357E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.09730000536135E-08 |
| Normal-vs-Stage2 |
3.240200E-04 |
| Normal-vs-Stage3 |
7.5761000000063E-05 |
| Normal-vs-Stage4 |
2.062100E-03 |
| Stage1-vs-Stage2 |
6.985200E-01 |
| Stage1-vs-Stage3 |
8.914200E-01 |
| Stage1-vs-Stage4 |
7.824800E-01 |
| Stage2-vs-Stage3 |
7.944400E-01 |
| Stage2-vs-Stage4 |
9.911600E-01 |
| Stage3-vs-Stage4 |
8.422200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.34690000556049E-09 |
| Normal-vs-AfricanAmerican |
5.57839999999477E-05 |
| Normal-vs-Asian |
8.880300E-02 |
| Caucasian-vs-AfricanAmerican |
4.390800E-01 |
| Caucasian-vs-Asian |
3.547400E-01 |
| AfricanAmerican-vs-Asian |
6.031400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39459999104474E-09 |
| Normal-vs-Female |
5.755900E-03 |
| Male-vs-Female |
3.136000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.573510E-04 |
| Normal-vs-Extreme_Weight |
1.07530000459377E-08 |
| Normal-vs-Obese |
4.07879999997363E-06 |
| Normal-vs-Extreme_Obese |
3.061500E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.916000E-01 |
| Normal_Weight-vs-Obese |
8.724200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.751600E-01 |
| Extreme_Weight-vs-Obese |
3.949600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.795400E-01 |
| Obese-vs-Extreme_Obese |
8.843400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.242200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.49850000000329E-06 |
| Normal-vs-Age(61-80Yrs) |
9.93280013794617E-10 |
| Normal-vs-Age(81-100Yrs) |
7.87859999999974E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.025600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.670400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.180950E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.759700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.270200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.396600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.68840002773885E-09 |
| Normal-VS-Type2 PRCC |
3.7181000001052E-07 |
| Normal-VS-KIRP CIMP |
4.622100E-03 |
| Normal-VS-Unclassified PRCC |
3.245000E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.358600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.265200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.841800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.518200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.284000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.928400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.90650004064474E-09 |
| Normal-vs-N1 |
2.978100E-03 |
| Normal-vs-N2 |
1.936360E-03 |
| N0-vs-N1 |
4.826300E-02 |
| N0-vs-N2 |
6.873400E-01 |
| N1-vs-N2 |
2.607200E-01 |
|
|
